New drug trial aims to shield stomachs from steroid side effects
NCT ID NCT05946135
Summary
This study tested whether a medication called fexuprazan could prevent or control gastritis (stomach lining irritation) in adults needing long-term steroid treatment for respiratory diseases. It compared fexuprazan against an existing stomach-protecting drug (lansoprazole) over four weeks. The goal was to see which drug better managed stomach symptoms in patients at risk for this common steroid side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS ON TREATMENT WITH SYSTEMIC STEROIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.